Perspective > Medscape Diabetes & Endocrinology Elizabeth Selvin, PhD, MPH DISCLOSURES March 20, 2024 Continuous glucose monitoring (CGM) has revolutionized diabetes care, especially for patients with type 1 diabetes. CGM is also increasingly being used for patients with type 2 diabetes as well as managing diabetes during pregnancy. As the adoption of this technology grows,...
by Karen Kreeger, Monell Chemical Senses Center MAY 18, 2024 Credit: Unsplash/CC0 Public Domain The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of four teams in 2001 that found and described the mammalian sweet taste receptor—TAS1R2-TAS1R3. Twenty years later in 2021, a pair...
by JooHyeon Heo,Ulsan National Institute of Science and Technology EM-based subcutaneous implant glucose sensor. (a) Illustration of EM-based implantable sensor for BGL tracking; (1) blood capillary (2) electromagnetic sensor (3) dermis (4) subcutaneous fat (5) muscle tissue. (b) Proposed implant sensor. (c) Sensor size (15 mm × 4 mm ∅) compared with a coin. (d) Sensor frequency...
by Kennesaw State University A new non-invasive blood glucose monitoring process is in development. Credit: Kennesaw State University As a child, Maria Valero witnessed her diabetic father prick his finger several times a day to draw blood and check his glucose levels using an electronic monitor. She was concerned about the invasive and painful process...
Among patients with type 1 diabetes, percentage of time in the target glucose range is increased with the use of an open-source automated insulin delivery (AID) system, according to a study published in the Sept. 8 issue of the New England Journal of Medicine. Mercedes J. Burnside, M.B., Ch.B., from the University of Otago in New...
by Gabrielle Stewart, Pennsylvania State University Penn State researchers developed a prototype of a wearable, noninvasive glucose sensor, shown here on the arm. Credit: Jia Zhu Noninvasive glucose monitoring devices are not currently commercially available in the United States, so people with diabetes must collect blood samples or use sensors embedded under the skin to measure their blood...
Metabolically driven autonomous motility is the key indicator of life, ubiquitous in all living organisms including molecules, proteins, and organelles. For example, bacteria can ingeniously swim towards higher glucose concentration or escape from toxic chemical environment through autonomous motility. Recently, a research team at POSTECH has devised a biocompatible nanomotor that artificially realizes movement by mimicking the...
by eLife Credit: CC0 Public Domain Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study published today in eLife. The results pave the way for clinical studies of the new drug combination as a more effective long-term treatment...
by University of Tokyo The trans-omic network includes regulatory pathways that are specific to obese mice and those specific to healthy mice. Color coding highlights pathways that respond to glucose only in normal-weight mice (WT, blue), only obese mice (ob/ob, red), pathways in common (green), and pathways that react in opposite ways in obese and normal-weight...
INSTITUTE OF INDUSTRIAL SCIENCE, THE UNIVERSITY OF TOKYO Tokyo, Japan — Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few. Now, a team of researchers led by Beomjoon Kim at the Institute of Industrial Science, The University of Tokyo...
